{"id":59472,"date":"2023-01-25T11:20:53","date_gmt":"2023-01-25T00:50:53","guid":{"rendered":"https:\/\/www.aumanufacturing.com.au\/?p=59472"},"modified":"2023-01-25T11:20:53","modified_gmt":"2023-01-25T00:50:53","slug":"lbt-innovations-and-astrazeneca-to-develop-ai-systems","status":"publish","type":"post","link":"https:\/\/www.aumanufacturing.com.au\/lbt-innovations-and-astrazeneca-to-develop-ai-systems","title":{"rendered":"LBT Innovations and AstraZeneca to develop AI systems"},"content":{"rendered":"
Microbiology diagnostic equipment manufacturer LBT Innovations has partnered with AstraZeneca and Thermo Fisher to speed up the development of LBT’s APAS AI software platform for microbial testing in the pharmaceutical sector.<\/p>\n
The software, seen on LBT’s APAS Independence laboratory instrument, speeds up the laboratory processing of clinical samples by utilising AI to scan for microbial contamination.<\/p>\n
LBT said the partnership opened up a new market for the company with the opportunity ‘estimated at $10 billion’.<\/p>